Original title
Pill
Released
7/12/2024
Origin country
IN
Genre
Drama
Production companies
RSVP Movies
Status
Ended
Number of seasons
1
Number of episodes
8
Pill unravels the deep-set rot in the Indian pharmaceutical industry. Dr. Prakash along with three whistle-blowers face a powerful pharma giant Forever Cure to expose the corrupt nexus of pharma, middlemen, and doctors through which a pill reaches the common man. Will the good be able to overcome the evil?
Dr. Prakash uncovers dysfunction within the Medicine Authority of India while Forever Cure Pharma eyes expansion, sparking a clash of interests and ethical dilemmas.
Noor, the journalist finds a dossier on a discontinued antibiotic by Forever Cure Pharma. Dr. Prakash learns of a failed inspection at their Gurgaon facility. Suspicion grows, leading to a compelling investigation.
Noor shares scant details of the discontinued antibiotic on social media, catching Gursimrat's attention, who informs Dr. Prakash. Despite Neelima's dismissal, Dr. Prakash persists, determined to join forces with Noor in their quest for truth.
Forever Cure Pharma's CEO, Bramha Gill, stunned by outcry over trial deaths, seeks CM's help. Dr. Prakash orders Gurgaon plant re-inspection; no evidence found. An insider who discovers the truth is being forced to shut down.
Amidst damaging articles, Bramha Gill rushes to the US for FMA approval of their cancer drug. Dr. Prakash faces a setback when he finds his mentor has joined hands with the enemy. Determined, Prakash opts to meet MCGI's Mr. Raman.
Denied by superiors, Prakash takes Forever Cure Pharma to court for plant inspection. Court orders an inspection only to uncover the rot in the practices of Forever cure pharma.
Dr. Prakash decides to test drugs by his own means but faces a setback. Yet he approaches the supreme court, what is up his sleeve?
It is race against time for Dr, Prakash and team in court. Their only hope, Ashish struggles for his life in a hit and run attack. Will the common man win?
This website uses TMDB and the TMDB APIs but is not endorsed, certified, or otherwise approved by TMDB.
